论文信息 - Phase II open-label study of bevacizumab combined with neoadjuvant anthracycline and taxane therapy for locally advanced breast cancer. - 字舞流文

Phase II open-label study of bevacizumab combined with neoadjuvant anthracycline and taxane therapy for locally advanced breast cancer.

O. Garrone | L. Del Mastro | A. Gallì | E. Aitini | G. Bisagni | R. Scalamogna | E. Restuccia | M. Clavarezza | A. Durando | C. Bighin | A. Levaggi | S. Saracchini | M. Turazza | S. De Placido